Factors related to age at depression onset: the role of SLC6A4 methylation, sex, exposure to stressful life events and personality in a sample of inpatients suffering from major depression.
5-HTTLPR
Age at onset
DNA methylation
Major depression
Primary emotions
SLC6A4
Stress
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
25 03 2021
25 03 2021
Historique:
received:
08
12
2020
accepted:
12
03
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
4
2021
Statut:
epublish
Résumé
An early onset of depression is associated with higher chronicity and disability, more stressful life events (SLEs), higher negative emotionality as described by the primary emotion SADNESS and more severe depressive symptomatology compared to depression onset later in life. Additionally, methylation of the serotonin transporter gene (SLC6A4) is associated with SLEs and depressive symptoms. We investigated the relation of SLEs, SLC6A4 methylation in peripheral blood, the primary emotions SADNESS and SEEKING (measured by the Affective Neuroscience Personality Scales) as well as depressive symptom severity to age at depression onset in a sample of N = 146 inpatients suffering from major depression. Depressed women showed higher SADNESS (t (91.05) = - 3.17, p = 0.028, d = - 0.57) and higher SLC6A4 methylation (t (88.79) = - 2.95, p = 0.02, d = - 0.55) compared to men. There were associations between SLEs, primary emotions and depression severity, which partly differed between women and men. The Akaike information criterion (AIC) indicated the selection of a model including sex, SLEs, SEEKING and SADNESS for the prediction of age at depression onset. SLC6A4 methylation was not related to depression severity, age at depression onset or SLEs in the entire group, but positively related to depression severity in women. Taken together, we provide further evidence that age at depression onset is associated with SLEs, personality and depression severity. However, we found no associations between age at onset and SLC6A4 methylation. The joint investigation of variables originating in biology, psychology and psychiatry could make an important contribution to understanding the development of depressive disorders by elucidating potential subtypes of depression.
Sections du résumé
BACKGROUND
An early onset of depression is associated with higher chronicity and disability, more stressful life events (SLEs), higher negative emotionality as described by the primary emotion SADNESS and more severe depressive symptomatology compared to depression onset later in life. Additionally, methylation of the serotonin transporter gene (SLC6A4) is associated with SLEs and depressive symptoms.
METHODS
We investigated the relation of SLEs, SLC6A4 methylation in peripheral blood, the primary emotions SADNESS and SEEKING (measured by the Affective Neuroscience Personality Scales) as well as depressive symptom severity to age at depression onset in a sample of N = 146 inpatients suffering from major depression.
RESULTS
Depressed women showed higher SADNESS (t (91.05) = - 3.17, p = 0.028, d = - 0.57) and higher SLC6A4 methylation (t (88.79) = - 2.95, p = 0.02, d = - 0.55) compared to men. There were associations between SLEs, primary emotions and depression severity, which partly differed between women and men. The Akaike information criterion (AIC) indicated the selection of a model including sex, SLEs, SEEKING and SADNESS for the prediction of age at depression onset. SLC6A4 methylation was not related to depression severity, age at depression onset or SLEs in the entire group, but positively related to depression severity in women.
CONCLUSIONS
Taken together, we provide further evidence that age at depression onset is associated with SLEs, personality and depression severity. However, we found no associations between age at onset and SLC6A4 methylation. The joint investigation of variables originating in biology, psychology and psychiatry could make an important contribution to understanding the development of depressive disorders by elucidating potential subtypes of depression.
Identifiants
pubmed: 33765975
doi: 10.1186/s12888-021-03166-6
pii: 10.1186/s12888-021-03166-6
pmc: PMC7995700
doi:
Substances chimiques
SLC6A4 protein, human
0
Serotonin Plasma Membrane Transport Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
167Investigateurs
Bernhard J Connemann
(BJ)
Maximilian Gahr
(M)
Thomas Kammer
(T)
Commentaires et corrections
Type : ErratumIn
Références
Aging Ment Health. 2022 Apr;26(4):828-833
pubmed: 33522286
J Pers Soc Psychol. 2008 Jan;94(1):168-182
pubmed: 18179326
Front Psychol. 2017 Apr 11;8:464
pubmed: 28443039
Depress Anxiety. 2003;17(4):226-8
pubmed: 12820180
Genes Dev. 1988 Sep;2(9):1136-43
pubmed: 3192075
Curr Psychiatry Rep. 2017 Aug;19(8):43
pubmed: 28608123
Psychopathology. 2015;48(6):400-7
pubmed: 26555606
Brain Behav. 2016 May 03;6(8):e00486
pubmed: 27247856
Am J Hum Genet. 2006 May;78(5):815-826
pubmed: 16642437
J Affect Disord. 2003 Apr;74(2):131-8
pubmed: 12706514
Neurosci Biobehav Rev. 2017 Jan;72:190-209
pubmed: 27880876
J Affect Disord. 2015 Jul 15;180:179-84
pubmed: 25911132
J Neural Transm Gen Sect. 1994;95(2):157-62
pubmed: 7865169
Mol Psychiatry. 2016 Apr;21(4):516-22
pubmed: 26122587
Front Genet. 2015 Sep 17;6:287
pubmed: 26442105
Am J Psychiatry. 2013 Sep;170(9):1041-50
pubmed: 24030613
Life Sci. 2018 Oct 1;210:106-124
pubmed: 30144453
Eur J Neurosci. 2011 Mar;33(6):1152-9
pubmed: 21395859
Am J Psychiatry. 2000 Oct;157(10):1552-62
pubmed: 11007705
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:125-131
pubmed: 30201454
Psychol Rev. 1992 Jul;99(3):554-560
pubmed: 1502276
Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):543-9
pubmed: 17987668
Epidemiol Psychiatr Sci. 2018 Oct;27(5):430-432
pubmed: 29804550
J Affect Disord. 2020 Nov 1;276:829-838
pubmed: 32738668
Depress Anxiety. 2009;26(8):718-23
pubmed: 19496077
Biol Psychiatry. 2007 Sep 1;62(5):423-8
pubmed: 17482146
J Clin Psychiatry. 2003 Jun;64(6):663-7
pubmed: 12823080
Nature. 1986 May 15-21;321(6067):209-13
pubmed: 2423876
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:23-8
pubmed: 23333376
Biol Psychol. 2010 Feb;83(2):159-65
pubmed: 20018225
Transl Psychiatry. 2017 May 30;7(5):e1139
pubmed: 28556831
Nat Struct Mol Biol. 2009 Jun;16(6):652-7
pubmed: 19430461
Am J Psychiatry. 2006 Jan;163(1):109-14
pubmed: 16390897
Am J Psychiatry. 1995 Jun;152(6):833-42
pubmed: 7755111
Personal Neurosci. 2018 Aug 10;1:e12
pubmed: 32435731
Psychiatry. 2011 Spring;74(1):5-13
pubmed: 21463165
Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):710-713
pubmed: 19739105
J Affect Disord. 2005 May;86(1):81-6
pubmed: 15820274
Mol Neurobiol. 2017 Dec;54(10):8386-8403
pubmed: 27933583
Arch Gen Psychiatry. 1973 Jan;28(1):19-24
pubmed: 4683141
J Nerv Ment Dis. 2009 Mar;197(3):154-60
pubmed: 19282680
Annu Rev Clin Psychol. 2011;7:1-38
pubmed: 21275642
J Abnorm Psychol. 2000 Nov;109(4):753-60
pubmed: 11196001
J Am Acad Child Adolesc Psychiatry. 2020 Jul;59(7):842-855
pubmed: 31676392
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Neurosci Biobehav Rev. 2020 Nov;118:163-174
pubmed: 32681937
Mol Psychiatry. 2018 Jan;23(1):133-142
pubmed: 28373689
Nat Neurosci. 2007 Sep;10(9):1103-9
pubmed: 17726476
Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):859-68
pubmed: 22915352
J Neurochem. 1996 Jun;66(6):2621-4
pubmed: 8632190
J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):460-70
pubmed: 21515195
Nat Rev Genet. 2012 Jan 04;13(2):97-109
pubmed: 22215131
J Psychiatry Neurosci. 2015 Sep;40(5):296-305
pubmed: 25825812
Front Neurosci. 2019 Jan 17;12:1025
pubmed: 30705615
Hum Genet. 1995 Jun;95(6):677-80
pubmed: 7789954
Psychol Med. 2001 May;31(4):605-16
pubmed: 11352363
J Mol Neurosci. 2020 Feb;70(2):201-211
pubmed: 31768943
J Affect Disord. 2012 May;138(3):259-67
pubmed: 22370067
BMJ Open. 2019 Jun 27;9(6):e024886
pubmed: 31248914
J Psychiatr Res. 2013 Sep;47(9):1222-7
pubmed: 23702251
Mol Psychiatry. 2018 Dec;23(12):2324-2346
pubmed: 30038230
Psychosom Med. 2013 Jul-Aug;75(6):523-9
pubmed: 23766378
Depress Anxiety. 2013 Dec;30(12):1151-60
pubmed: 23959810
JAMA Psychiatry. 2013 Oct;70(10):1100-6
pubmed: 23986338
Psychoneuroendocrinology. 2013 Sep;38(9):1858-73
pubmed: 23838101
Arch Gen Psychiatry. 2005 Oct;62(10):1097-106
pubmed: 16203955
J Gerontol B Psychol Sci Soc Sci. 2003 Nov;58(6):P320-8
pubmed: 14614116
Am J Psychiatry. 2014 Aug;171(8):872-880
pubmed: 24832930
JAMA. 1996 Jul 24-31;276(4):293-9
pubmed: 8656541
Biol Mood Anxiety Disord. 2015 May 14;5:2
pubmed: 25995833
Biochem Soc Trans. 2001 Nov;29(Pt 6):722-8
pubmed: 11709063
J Abnorm Psychol. 2011 Nov;120(4):779-96
pubmed: 21928863
Pediatrics. 2016 Dec;138(6):
pubmed: 27940701
Ann N Y Acad Sci. 2006 Dec;1094:202-14
pubmed: 17347352
Nature. 2007 May 24;447(7143):396-8
pubmed: 17522671
Transl Psychiatry. 2014 Sep 16;4:e443
pubmed: 25226552
J Abnorm Psychol. 2006 Nov;115(4):730-41
pubmed: 17100530
Compr Psychiatry. 2017 Feb;73:136-142
pubmed: 27940318
J Affect Disord. 2013 May;147(1-3):17-28
pubmed: 23411024
Neurosci Biobehav Rev. 2014 Jun;43:228-39
pubmed: 24769290
J Abnorm Child Psychol. 2009 Oct;37(7):903-15
pubmed: 19437113
Pharmacopsychiatry. 1996 Jan;29(1):2-11
pubmed: 8852528
Nat Neurosci. 2014 Sep;17(9):1153-5
pubmed: 25086606
Lancet. 2009 Feb 28;373(9665):746-58
pubmed: 19185342
Lancet. 2018 Sep 22;392(10152):1010-1011
pubmed: 30264699